Bruker Corporation (NASDAQ:BRKR) Given Consensus Rating of “Hold” by Brokerages

Bruker Corporation (NASDAQ:BRKR) has been assigned a consensus recommendation of “Hold” from the fifteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $54.5385.

Several brokerages have recently commented on BRKR. UBS Group set a $60.00 price objective on Bruker in a research report on Wednesday, June 24th. Citigroup lifted their target price on Bruker from $40.00 to $44.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Weiss Ratings raised Bruker from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 3rd. TD Cowen lifted their target price on Bruker from $43.00 to $45.00 and gave the stock a “hold” rating in a report on Thursday, May 7th. Finally, Barclays lifted their target price on Bruker from $53.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th.

Insider Activity

In other news, VP Mark Munch sold 2,000 shares of Bruker stock in a transaction dated Wednesday, April 15th. The stock was sold at an average price of $39.90, for a total value of $79,800.00. Following the sale, the vice president directly owned 128,443 shares of the company’s stock, valued at approximately $5,124,875.70. The trade was a 1.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 27.20% of the company’s stock.

Institutional Investors Weigh In On Bruker

Large investors have recently made changes to their positions in the company. Allworth Financial LP increased its stake in Bruker by 40.6% during the third quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after acquiring an additional 257 shares during the last quarter. Federated Hermes Inc. increased its stake in Bruker by 6.7% during the fourth quarter. Federated Hermes Inc. now owns 6,027 shares of the medical research company’s stock worth $284,000 after acquiring an additional 380 shares during the last quarter. Parallel Advisors LLC increased its stake in Bruker by 121.0% during the fourth quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock worth $41,000 after acquiring an additional 479 shares during the last quarter. State of Michigan Retirement System increased its stake in Bruker by 1.9% during the first quarter. State of Michigan Retirement System now owns 26,693 shares of the medical research company’s stock worth $964,000 after acquiring an additional 500 shares during the last quarter. Finally, CWM LLC increased its stake in Bruker by 49.8% during the fourth quarter. CWM LLC now owns 1,631 shares of the medical research company’s stock worth $77,000 after acquiring an additional 542 shares during the last quarter. 79.52% of the stock is owned by institutional investors.

Bruker Price Performance

Shares of Bruker stock opened at $60.18 on Wednesday. The stock’s 50-day simple moving average is $49.30 and its 200-day simple moving average is $44.68. Bruker has a 52 week low of $28.53 and a 52 week high of $64.54. The company has a market capitalization of $9.16 billion, a price-to-earnings ratio of -250.75, a PEG ratio of 1.91 and a beta of 1.31. The company has a quick ratio of 0.72, a current ratio of 1.55 and a debt-to-equity ratio of 0.67.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings data on Wednesday, May 6th. The medical research company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.23 by $0.08. Bruker had a positive return on equity of 11.60% and a negative net margin of 0.65%.The business had revenue of $823.40 million for the quarter, compared to the consensus estimate of $795.62 million. During the same period in the previous year, the business earned $0.47 earnings per share. The business’s revenue was up 2.7% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, analysts expect that Bruker will post 2.12 earnings per share for the current fiscal year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 7th. Stockholders of record on Monday, June 22nd will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, June 22nd. Bruker’s payout ratio is -83.33%.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.